🇺🇸 FDA
Patent

US 7763451

Methods for preparing Bacillus anthracis protective antigen for use in vaccines

granted A61KA61K2039/505A61K2039/53

Quick answer

US patent 7763451 (Methods for preparing Bacillus anthracis protective antigen for use in vaccines) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K2039/505, A61K2039/53, A61K39/00, A61P